Ji-rong Yang
Is A Technical Specialist
Ji Rong Yang, TPQ, Taiwan
Ji Rong Yang, TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
The National Laboratory Response to the COVID-19 Pandemic in Taiwan.
Journal: Health security
Published: September 15, 2022
Influenza A virus NS1 protein represses antiviral immune response by hijacking NF-κB to mediate transcription of type III IFN.
Journal: Frontiers in cellular and infection microbiology
Published: July 20, 2022
Evaluation of conventional and point-of-care real-time RT-PCR tests for the detection of SARS-CoV-2 through a pooled testing strategy.
Journal: Journal of clinical laboratory analysis
Published: February 13, 2022
Human infection with a reassortant swine-origin influenza A(H1N2)v virus in Taiwan, 2021.
Journal: Virology journal
Published: January 14, 2022
Clinical Comparison of Three Sample-to-Answer Systems for Detecting SARS-CoV-2 in B.1.1.7 Lineage Emergence.
Journal: Infection and drug resistance
Published: July 07, 2021
Multicenter study evaluating novel multi-specimen pooling assay for the detection of SARS-CoV-2: High sensitivity and high throughput testing.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: June 18, 2021
Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: Biosafety Level-3 and -4 Labs.
Journal: Frontiers in bioengineering and biotechnology
Published: June 04, 2021
Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system.
Journal: Emerging microbes & infections
Published: January 07, 2021
Investigation of One Familial Cluster of COVID-19 in Taiwan: Differentiation of Genetic Variation Among Isolates and Implications for Epidemiological Investigation and Surveillance by Genomic Assay.
Journal: Infection and drug resistance
Published: December 22, 2020
A cross-neutralizing antibody between HIV-1 and influenza virus.
Journal: PLoS pathogens
Published: September 21, 2020
Building the National SARS-CoV-2 Laboratory Diagnostic Capacity in Taiwan.
Journal: Health security
Published: August 22, 2020
Last Updated: 09/26/2026